Comparison Of The Efficacy And Safety Of Secukinumab, Ustekinumab And Guselkumab For The Treatment Of Moderate To Severe Plaque Psoriasis: A Systematic Review. Journal of Pharmaceutical Negative Results 2023, 485-495. https://doi.org/10.47750/pnr.2023.14.02.62.